- Medical Devices
- Friday, 23 Aug 2019
Gastric Balloon Market to double up by 2027 US$ 152.1 Mn
The gastric balloon is a niche market in nature with limited number of players, having considerable revenue in the market. Most of the companies operating in the gastric balloon market are offering their products in the European and the Middle East region, whereas, only three products have FDA approvals for the commercialization of their products.
The most notable market participants are Apollo Endosurgery, Inc. and Allurion Technologies, Inc., ENDALIS, Helioscopie Medical Implants, LEXEL SRL, MEDSIL, Obalon Therapeutics, Inc., ReShape Lifesciences, Inc., Silimed, and Spatz FGIA, Inc. occupying a considerable share of the market owing to their offerings to the market.
Market leaders are involved in activities such as, obtaining approvals to serve a better customer base. For instance, In December, 2018, Obalon received FDA approval of the Obalon Navigation System, which eliminates the need to use x-ray when placing the Obalon Balloon System. The Obalon Navigation System and Touch Inflation Dispenser are expected to be commercially available during the first quarter of 2019 in the United States. Also, during February, 2018, Apollo received approval from the South Korean Ministry of Food and Drug Safety’s (MFDS) for the ORBERA Intragastric Balloon System. Shin Han Systek Co. Ltd. was declared as the exclusive distributor for ORBERA in South Korea. Owing to these approvals, it has been possible for the companies to serve larger customer base as well as provide better weight loss solutions to the patients.
The global gastric balloon market is expected to reach US$ 152.1 Mn in 2027 from US$ 67.3 Mn in 2018. The gastric balloon market is estimated to grow with a CAGR of 9.7% from 2019-2027.
Along with obtaining approvals, various companies have signed agreements in order to strengthen as well as extend its customer base. Additionally various companies are also undergoing other strategic alliances such as collaboration partnerships to garner their significance and remain competitive in the market.
Related Industry Updates
Roche Launches New Cobas Pro Integrated Solutions to Significantly Reduce Manual Operations in Labs
Sep 05, 2019
Asia Pacific Intraoperative Neuromonitoring Market To See Massive Growth By 2027 | Medtronic, Nihon Kohden Corporation, Nuvasive, Specialtycare
Feb 02, 2021
Extracorporeal CO2 Removal Devices Market is expected to reach US$ 170.54 million by 2030
Feb 13, 2024
Bedpan Macerator Market Pegged for Robust Expansion by 2027
Jan 08, 2021
Confocal Microscopes Market Summary Comprises Key Regions, Growth, Segmentation Till 2027
Dec 18, 2020
Revolutionary Developments Shaping Medical Technology Market
Oct 16, 2019
Medical Apron Market Set for Rapid Growth by 2027
Mar 15, 2021